Duncan Odom | |
---|---|
Born | Duncan Odom |
Alma mater | |
Awards |
|
Scientific career | |
Fields | |
Institutions | |
Thesis | The application of metallointercalators in recognition of and charge transport in nucleic acids (2001) |
Doctoral advisor | Jacqueline Barton[5] |
Other academic advisors | Richard A. Young[6] |
Doctoral students | Christina Ernst[7] |
Website | www |
Duncan Odom is a research group leader at the German Cancer Research Center (DKFZ) in Heidelberg, and the Cancer Research UK Cambridge Institute (CRUK CI) at the University of Cambridge.[3][8][6] Previously he was as an associate faculty member at the Wellcome Trust Sanger Institute from 2011 to 2018.[4]
Odom was educated at the New College of Florida where he was awarded a Bachelor of Arts degree in Chemistry in 1995.[4] He continued his study at California Institute of Technology (Caltech) where he was awarded a PhD in chemical engineering for research on DNA-binding metallo-intercalators supervised by Jacqueline Barton.[6][5]
After a period as a postdoctoral researcher[9] in genetics and genomics at the Whitehead Institute in Cambridge, Massachusetts with Richard A. Young,[4] he established his research group at the University of Cambridge in 2006.[6] His research investigates how transcription and transcriptional regulation vary during evolution, and its implications for diseases such as cancer, using high throughput biology methods to investigate genome evolution.[10][11][12][13] As of 2017[update], according to Google Scholar his most highly-cited papers have been published in Cell,[14] Chemical Reviews,[15] and Science.[16][17]
His research has been funded by the National Institute of Diabetes and Digestive and Kidney Diseases,[6] the Alfred P. Sloan Foundation, the European Research Council (ERC),[citation needed] the European Molecular Biology Organization (EMBO), the Wellcome Trust[18] and Cancer Research UK.[6] His former doctoral students include Christina Ernst.[7]
Odom was awarded the Crick Lecture by the Royal Society in 2014[1][19] for his "pioneering work in the field of comparative functional genomics, which has changed our understanding of the evolution of mammalian transcriptional regulation."[1] He was awarded EMBO Membership in 2015,[2] and the Mary F. Lyon Medal from The Genetics Society in 2016.[20]